US takes immigration issue 'incredibly seriously': State Dept amid visa delays
Addressing the US State Department briefing on Thursday, Principal Deputy Spokesperson Vedant Patel addressed the immigration ...
Sagimet: More Than Just A MASH Drug Development Biotech
Sagimet Biosciences eyes major opportunities in MASH and Acne treatments. Find out why SGMT stock is a solid pick with upcoming phase 3 study results.